NASDAQ: FRPTFreshpet Inc Stock
$66.19+0.31 (+0.47%)
Updated Mar 31, 2023
FRPT Price
$66.19
Fair Value Price
$69.06
Market Cap
$3.18B
52 Week Low
$36.02
52 Week High
$118.77
P/E
-51.31x
P/B
3.08x
P/S
4.09x
PEG
N/A
Dividend Yield
N/A
Revenue
$595.34M
Earnings
-$59.49M
Gross Margin
31.2%
Operating Margin
-9.07%
Profit Margin
-10%
Debt to Equity
0.09
Operating Cash Flow
-$43M
Beta
1.27
Next Earnings
May 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A
FRPT Overview
Freshpet, Inc. manufactures and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe. The company sells its products under the Freshpet brand; and Dognation and Dog Joy labels through various classes of retail, including grocery, mass, club, pet specialty, and natural, as well as online. Freshpet, Inc. was incorporated in 2004 and is headquartered in Secaucus, New Jersey.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FRPT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FRPT ($66.19) is undervalued by 4.16% relative to our estimate of its Fair Value price of $69.06 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
FRPT ($66.19) is not significantly undervalued (4.16%) relative to our estimate of its Fair Value price of $69.06 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
FRPT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more FRPT due diligence checks available for Premium users.
Be the first to know about important FRPT news, forecast changes, insider trades & much more!
FRPT News
Valuation
FRPT fair value
Fair Value of FRPT stock based on Discounted Cash Flow (DCF)
Price
$66.19
Fair Value
$69.06
Undervalued by
4.16%
FRPT ($66.19) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FRPT ($66.19) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FRPT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
FRPT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-51.31x
Industry
20.18x
Market
22.13x
FRPT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.08x
Industry
2.41x
FRPT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FRPT's financial health
Profit margin
Revenue
$165.8M
Net Income
-$2.9M
Profit Margin
-1.8%
FRPT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
FRPT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.1B
Liabilities
$93.8M
Debt to equity
0.09
FRPT's short-term assets ($261.97M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FRPT's short-term assets ($261.97M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FRPT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FRPT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$10.5M
Investing
-$42.8M
Financing
-$75.2M
FRPT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FRPT vs Food Stocks
Freshpet Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.